Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD

NCT03388385 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Renal Anemia
Iron Toxicity
Oxidative Stress
Endothelial Dysfunction

Interventions

DRUG: Sodium Chloride 0.9% Intravenous Solution
DRUG: Ferinject

Sponsor

Carol Davila University of Medicine and Pharmacy

Collaborators

[object Object]